Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 3
1987 1
1988 1
1989 3
1990 2
1991 1
1993 3
1994 6
1995 4
1996 11
1997 4
1998 8
1999 8
2000 13
2001 3
2002 14
2003 23
2004 24
2005 26
2006 30
2007 34
2008 40
2009 53
2010 47
2011 64
2012 68
2013 97
2014 112
2015 136
2016 147
2017 154
2018 152
2019 198
2020 264
2021 293
2022 330
2023 306
2024 93

Text availability

Article attribute

Article type

Publication date

Search Results

2,446 results

Results by year

Filters applied: . Clear all
Page 1
Evolving therapeutic landscape of advanced hepatocellular carcinoma.
Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C. Yang C, et al. Among authors: zhu ax. Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36369487 Review.
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.
Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu CH, He AR, Ryoo BY, Yau T, Kaseb AO, Burgoyne AM, Dayyani F, Spahn J, Verret W, Finn RS, Toh HC, Lujambio A, Wang Y. Zhu AX, et al. Nat Med. 2022 Aug;28(8):1599-1611. doi: 10.1038/s41591-022-01868-2. Epub 2022 Jun 23. Nat Med. 2022. PMID: 35739268
Efficacy of vitamin D3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials.
Kuznia S, Zhu A, Akutsu T, Buring JE, Camargo CA Jr, Cook NR, Chen LJ, Cheng TD, Hantunen S, Lee IM, Manson JE, Neale RE, Scragg R, Shadyab AH, Sha S, Sluyter J, Tuomainen TP, Urashima M, Virtanen JK, Voutilainen A, Wactawski-Wende J, Waterhouse M, Brenner H, Schöttker B. Kuznia S, et al. Among authors: zhu a. Ageing Res Rev. 2023 Jun;87:101923. doi: 10.1016/j.arr.2023.101923. Epub 2023 Mar 31. Ageing Res Rev. 2023. PMID: 37004841 Free PMC article.
Structures and mechanisms of the Arabidopsis auxin transporter PIN3.
Su N, Zhu A, Tao X, Ding ZJ, Chang S, Ye F, Zhang Y, Zhao C, Chen Q, Wang J, Zhou CY, Guo Y, Jiao S, Zhang S, Wen H, Ma L, Ye S, Zheng SJ, Yang F, Wu S, Guo J. Su N, et al. Among authors: zhu a. Nature. 2022 Sep;609(7927):616-621. doi: 10.1038/s41586-022-05142-w. Epub 2022 Aug 2. Nature. 2022. PMID: 35917926
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation.
Gao J, Wang Z, Jiang W, Zhang Y, Meng Z, Niu Y, Sheng Z, Chen C, Liu X, Chen X, Liu C, Jia K, Zhang C, Liao H, Jung J, Sung E, Chung H, Zhang JZ, Zhu AX, Shen L. Gao J, et al. Among authors: zhu ax. J Immunother Cancer. 2023 Jun;11(6):e006704. doi: 10.1136/jitc-2023-006704. J Immunother Cancer. 2023. PMID: 37364935 Free PMC article.
2,446 results